Aripiprazole
031-05-002-C
Approved small_molecule completed
Quick answer
Aripiprazole for Schizophrenia is a Approved program (small_molecule) at Otsuka Beijing Research Institute with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Otsuka Beijing Research Institute
- Indication
- Schizophrenia
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed